Cwm, LLC Gilead Sciences, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cwm, LLC holds 365,275 shares of GILD stock, worth $34.3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

365,275

Previous 391,832 6.78%

Holding current value

$34.3 Million

Previous $26.9 Million 13.92%

% of portfolio

0.13%

Previous 0.13%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$66.59 - $83.99 $1.77 Million - $2.23 Million	-26,557 Reduced 6.78%	365,275 $30.6 Million
Q2 2024 Jul 09, 2024	BUY	$63.15 - $72.88 $1.05 Million - $1.21 Million	16,616 Added 4.43%	391,832 $26.9 Million
Q1 2024 Apr 05, 2024	SELL	$71.58 - $87.29 $279,591 - $340,954	-3,906 Reduced 1.03%	375,216 $27.5 Million
Q4 2023 Feb 01, 2024	SELL	$73.27 - $83.09 $913,603 - $1.04 Million	-12,469 Reduced 3.18%	379,122 $30.7 Million
Q3 2023 Oct 11, 2023	BUY	$73.94 - $80.67 $205,701 - $224,423	2,782 Added 0.72%	391,591 $29.3 Million
Q2 2023 Aug 03, 2023	SELL	$76.01 - $86.7 $3.49 Million - $3.98 Million	-45,858 Reduced 10.55%	388,809 $30 Million
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $5.92 Million - $6.74 Million	-76,539 Reduced 14.97%	434,667 $36.1 Million
Q4 2022 Feb 01, 2023	BUY	$62.32 - $89.47 $302,376 - $434,108	4,852 Added 0.96%	511,206 $43.9 Million
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $929,002 - $1.06 Million	15,603 Added 3.18%	506,354 $31.2 Million
Q2 2022 Jul 28, 2022	BUY	$57.72 - $65.01 $1.82 Million - $2.05 Million	31,516 Added 6.86%	490,751 $30.3 Million
Q1 2022 Apr 21, 2022	BUY	$57.92 - $72.58 $492,262 - $616,857	8,499 Added 1.89%	459,235 $27.3 Million
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $23.4 Million - $26.6 Million	361,155 Added 403.16%	450,736 $32.7 Million
Q1 2021 Sep 15, 2021	BUY	$60.0 - $68.46 $2.07 Million - $2.36 Million	34,532 Added 62.73%	89,581 $6.17 Million
Q1 2021 Apr 27, 2021	SELL	$60.0 - $68.46 $2.07 Million - $2.36 Million	-34,532 Reduced 38.55%	55,049 $3.56 Million
Q4 2020 Sep 15, 2021	BUY	$56.65 - $64.55 $4.66 Million - $5.31 Million	82,251 Added 1122.11%	89,581 $6.17 Million
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $4.66 Million - $5.31 Million	-82,251 Reduced 91.82%	7,330 $427,000
Q3 2020 Sep 15, 2021	BUY	$62.1 - $78.08 $5.07 Million - $6.38 Million	81,666 Added 1031.79%	89,581 $6.17 Million
Q3 2020 Oct 19, 2020	SELL	$62.1 - $78.08 $5.07 Million - $6.38 Million	-81,666 Reduced 91.16%	7,915 $500,000
Q2 2020 Sep 15, 2021	BUY	$72.34 - $84.0 $5.9 Million - $6.86 Million	81,612 Added 1024.12%	89,581 $6.17 Million
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $5.9 Million - $6.86 Million	-81,612 Reduced 91.1%	7,969 $613,000
Q1 2020 Sep 15, 2021	BUY	$62.63 - $80.22 $5.11 Million - $6.55 Million	81,618 Added 1024.97%	89,581 $6.17 Million
Q1 2020 Apr 28, 2020	SELL	$62.63 - $80.22 $5.11 Million - $6.55 Million	-81,618 Reduced 91.11%	7,963 $595,000
Q4 2019 Sep 14, 2021	BUY	$61.62 - $67.78 $4.9 Million - $5.39 Million	79,529 Added 791.18%	89,581 $6.17 Million
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $4.9 Million - $5.39 Million	-79,529 Reduced 88.78%	10,052 $653,000
Q3 2019 Sep 14, 2021	BUY	$62.51 - $69.0 $2.22 Million - $2.46 Million	35,580 Added 65.89%	89,581 $6.17 Million
Q3 2019 Oct 22, 2019	SELL	$62.51 - $69.0 $2.22 Million - $2.46 Million	-35,580 Reduced 39.72%	54,001 $3.42 Million
Q2 2019 Sep 14, 2021	BUY	$61.87 - $69.38 $2.05 Million - $2.3 Million	33,167 Added 58.79%	89,581 $6.17 Million
Q2 2019 Jul 31, 2019	SELL	$61.87 - $69.38 $2.05 Million - $2.3 Million	-33,167 Reduced 37.02%	56,414 $3.81 Million
Q1 2019 Sep 02, 2021	BUY	$62.53 - $70.05 $2.12 Million - $2.37 Million	33,843 Added 60.72%	89,581 $0
Q1 2019 Apr 22, 2019	BUY	$62.53 - $70.05 $97,171 - $108,857	1,554 Added 2.87%	55,738 $3.62 Million
Q4 2018 Jan 25, 2019	SELL	$60.54 - $79.0 $424,748 - $554,264	-7,016 Reduced 11.46%	54,184 $3.39 Million
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $1.54 Million - $1.7 Million	21,601 Added 54.55%	61,200 $4.73 Million
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $3.66 Million - $4.27 Million	-56,420 Reduced 58.76%	39,599 $2.81 Million
Q1 2018 Apr 26, 2018	BUY	$72.84 - $88.8 $932,789 - $1.14 Million	12,806 Added 15.39%	96,019 $7.24 Million
Q4 2017 Jan 16, 2018	BUY	$71.15 - $83.52 $142,940 - $167,791	2,009 Added 2.47%	83,213 $5.96 Million
Q3 2017 Oct 16, 2017	BUY	$72.11 - $85.47 $5.86 Million - $6.94 Million	81,204	81,204 $6.58 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account